Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function

Infection and Immunity

Volumn 78, Issue 7, 2010, Pages 3272-3279

  Rodríguez Zapata, Manuel ^a,d   Matías, Marlene J ^a   Prieto, Alfredo ^a   Jonde, Marco A ^a   Monserrat, Jorge ^a   Sánchez, Lorenzo ^a   Reyes, Eduardo ^a   De La Hera, Antonio ^a,c   Alvarez Mon, Melchor ^a,b,c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c CSIC   (Spain)

^d HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GAMMA INTERFERON; GENTAMICIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PHORBOL MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD; BRUCELLOSIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; PHAGOCYTE DYSFUNCTION; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; BRUCELLOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77953941946     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01385-09     Document Type: Article

References (52)

1. Ahmed, K., K. A. Al-Matrouk, G. Martinez, K. Oishi, V. O. Rotimi, and T. Nagatake. 1999. Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. Am. J. Trop. Med. Hyg. 61:425-427.
2. Akbulut, H. H., S. S. Kilic, V. Bulut, and M. Ozden. 2005. Determination of intracellular cytokines produced by Th1 and Th2 cells using flow cytometry in patients with brucellosis. FEMS Immunol. Med. Microbiol. 45:253-258.
3. Akbulut, H., I. Celik, and A. Akbulut. 2007. Cytokine levels in patients with brucellosis and their relations with the treatment. Indian J. Med. Microbiol. 25:387-390.
4. Albillos, A., A. Hera, E. Reyes, J. Monserrat, L. Muñoz, M. Nieto, A. Prieto, E. Sanz, and M. Alvarez-Mon. 2004. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J. Hepatol. 40:624-631.
5. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337.
6. Araya, L. N., and A. J. Winter. 1990. Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect. Immun. 58:254-256.
7. Baldwin, C. L., and M. Parent. 2002. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet. Microbiol. 90:367-382.
8. Barquero-Calvo, E., E. Chaves-Olarte, D. S. Weiss, C. Guzmán-Verri, C. Chacón-Díaz, A. Rucavado, I. Moriyón, and E. Moreno. 2007. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2(7):e631.
9. Barquero-Calvo, E., R. Conde-Alvarez, C. Chacón-Díaz, L. Quesada-Lobo, A. Martirosyan, C. Guzmán-Verri, M. Iriarte, M. Mancek-Keber, R. Jerala, J. P. Gorvel, I. Moriyón, E. Moreno, and E. Chaves-Olarte. 2009. The differential interaction of Brucella and Ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens. PLoS One 4(6):e5893.
10. Bellón, J. M., L. Manzano, A. Larrad, G. N. Honduvilla, J. Bujan, and M. Alvarez-Mon. 1998. Endocrine and immune response to injury after open and laparoscopic cholecystectomy. Int. Surg. 83:24-27.
11. Billard, E., C. Cazevieille, J. Dornand, and A. Gross. 2005. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect. Immun. 73:8418-8424.
12. Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97:77-89.
13. Castaño, M. J., and J. Solera. 2009. Chronic brucellosis and persistence of Brucella melitensis DNA. J. Clin. Microbiol. 47:2084-2089.
14. Celli, J. 2006. Surviving inside a macrophage: the many ways of Brucella. Res. Microbiol. 157:93-98.
15. Celli, J., and J. P. Gorvel. 2004. Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr. Opin. Microbiol. 7:93-97.
16. Chakravortty, D., and M. Hensel. 2003. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 5:621-627. (Pubitemid 36645122)
17. Choi, H. J., H. Xu, Y. Geng, A. Colmone, H. Cho, and C. R. Wang. 2008. Bacterial infection alters the kinetics and function of iNKT cell responses. J. Leukoc. Biol. 84:1462-1471.
18. Copin, R., P. De Baetselier, Y. Carlier, J. J. Letesson, and E. Muraille. 2007. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. J. Immunol. 178:5182-5191.
19. Corbel, M. J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
20. Cutler, S. J., A. M. Whatmore, and N. J. Commander. 2005. Brucellosis - new aspects of an old disease. J. Appl. Microbiol. 98:1270-1281.
21. Dornand, J., A. Gross, V. Lafont, J. Liautard, J. Oliaro, and J. P. Liautard. 2002. The innate immune response against Brucella in humans. Vet. Microbiol. 90:383-394.
22. Dudal, S., C. Turriere, S. Bessoles, P. Fontes, F. Sanchez, J. Liautard, J. P. Liautard, and V. Lafont. 2006. Release of LL-37 by activated human Vγ9Vδ2 T cells: a microbicidal weapon against Brucella suis. J. Immunol. 177:5533-5539.
23. Enright, F. M., L. N. Araya, P. H. Elzer, G. E. Rowe, and A. J. Winter. 1990. Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus. Vet. Immunol. Immunopathol. 26: 171-182.
24. Fernandes, D. M., and C. L. Baldwin. 1995. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect. Immun. 63:1130-1133.
25. Galanakis, E., A. Makis, K. L. Bourantas, and Z. L. Papadopoulou. 2002. Interleukin-3 and interleukin-4 in childhood brucellosis. Infection 30:33-34.
26. Geissmann, F., C. Auffray, R. Palframan, C. Wirrig, A. Ciocca, L. Campisi, E. Narni-Mancinelli, and G. Lauvau. 2008. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 86:398-408.
27. Giambartolomei, G. H., M. V. Delpino, M. E. Cahanovich, J. C. Wallach, P. C. Baldi, C. A. Velikovsky, and C. A. Fossati. 2002. Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J. Infect. Dis. 186:252-259.
28. Godfroid, J., A. Cloeckaert, J. P. Liautard, S. Kohler, D. Fretin, K. Walravens, B. Garin-Bastuji, and J. J. Letesson. 2005. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 36:313-326.
29. Güler, M. L., N. G. Jacobson, U. Gubler, and K. M. Murphy. 1997. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol. 159:1767-1774.
30. Hirt, W., T. Nebe, and C. Birr. 1994. Phagotest and Bursttest (Phagoburst), test kits for study of phagocyte functions. Wien. Klin. Wochenschr. 106:250-252.
31. Howard, J. 2008. The IRG proteins: a function in search of a mechanism. Immunobiology 213:367-375.
32. Ko, J., and G. A. Splitter. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65-78.
33. Labro, M. T. 2000. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin. Microbiol. Rev. 13:615-650.
34. Ma, J., T. Chen, J. Mandelin, A. Ceponis, N. E. Miller, M. Hukkanen, G. F. Ma, and Y. T. Konttinen. 2003. Regulation of macrophage activation. Cell. Mol. Life Sci. 60:2334-2346.
35. Macedo, G. C., D. M. Magnani, N. B. Carvalho, O. Bruna-Romero, R. T. Gazzinelli, and S. C. Oliveira. 2008. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J. Immunol. 180:1080-1087.
36. Mantecón, M. L., M. P. Gutiérrez, M. P. Zarzosa, L. Fernández-Lago, J. D. Colmenero, N. Vizcaíno, M. A. Bratos, A. Almaraz, A. Cubero, M. F. Muñoz, A. Rodríguez Torres, and A. Orduña. 2008. Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis. J. Infect. 57:397-403.
37. Murphy, E. A., J. Sathiyaseelan, M. A. Parent, B. Zou, and C. L. Baldwin. 2001. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103:511-518.
38. Navarro, E., J. C. Segura, M. J. Castaño, and J. Solera. 2006. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin. Infect. Dis. 42:1266-1273.
39. Oliaro, J., S. Dudal, J. Liautard, J. B. Andrault, J. P. Liautard, and V. Lafont. 2005. Vγ9Vδ2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella. J. Leukoc. Biol. 77:652-660.
40. Paludan, S. R. 1998. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48:459-468.
41. Pappas, G., N. Akritidis, M. Bosilkovski, and E. Tsianos. 2005. Brucellosis. N. Engl. J. Med. 352:2325-2336.
42. Pappas, G., P. Papadimitriou, N. Akritidis, L. Christou, and E. V. Tsianos. 2006. The new global map of human brucellosis. Lancet Infect. Dis. 6:91-99.
43. Pasquali, P., R. Adone, L. C. Gasbarre, C. Pistoia, and F. Ciuchini. 2001. Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infect. Immun. 69:6541-6544.
44. Rodríguez, A., R. Abad, and A. Orduña. 1992. Species and biovars of the genus Brucella. Etiology of human brucellosis in Spain. Enferm. Infecc. Microbiol. Clin. 10:43-48. (In Spanish.)
45. Rodriguez-Torres, A., R. Landinez, and R. Abad. 1984. Species and biotypes of human brucellosis in Spain. Dev. Biol. Stand. 56:107-112.
46. Rodriguez-Zapata, M., I. Salmeron, L. Manzano, O. J. Salmeron, A. Prieto, and M. Alvarez-Mon. 1996. Defective interferon-gamma production by T-lymphocytes from patients with acute brucellosis. Eur. J. Clin. Invest. 26: 136-140.
47. Roop, R. M., II, B. H. Bellaire, M. W. Valderas, and J. A. Cardelli. 2004. Adaptation of the brucellae to their intracellular niche. Mol. Microbiol. 52:621-630.
48. Salcedo, S. P., M. I. Marchesini, H. Lelouard, E. Fugier, G. Jolly, S. Balor, A. Muller, N. Lapaque, O. Demaria, L. Alexopoulou, D. J. Comerci, R. A. Ugalde, P. Pierre, and J. P. Gorvel. 2008. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog. 4(2):e21.
49. Salmerón, I., M. Rodríguez-Zapata, O. Salmeron, L. Manzano, S. Vaquer, and M. Alvarez-Mon. 1992. Impaired activity of natural killer cells in patients with acute brucellosis. Clin. Infect. Dis. 15:764-770.
50. Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96:41-101.
51. Stevens, M. G., G. W. Pugh, Jr., and L. B. Tabatabai. 1992. Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice. Infect. Immun. 60:4407-4409.
52. Zhan, Y., and C. Cheers. 1993. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61:4899-4901.